Prostate Cancer
Prostate derived ETS factor (PDEF): A putative tumor metastasis suppressor - Abstract
August 3, 2011
Clamp ablation of the testes compared to bilateral orchiectomy as androgen deprivation therapy for advanced prostate cancer - Abstract
August 2, 2011
EAU guidelines on prostate cancer. P5art I: Screening, diagnosis, and treatment of clinically localised disease - Abstract
August 2, 2011
Role of endorectal magnetic resonance spectroscopic imaging in two different Gleason scores in prostate cancer - Abstract
August 2, 2011
Testosterone regulates tight junction proteins and influences prostatic autoimmune responses - Abstract
August 2, 2011
Surgical castration in hormone-refractory metastatic prostate cancer patients can be an alternative for medical castration - Abstract
August 1, 2011
The use of estramustine phosphate in the modern management of advanced prostate cancer - Abstract
August 1, 2011
Oncological and functional outcomes following open radical prostatectomy: How patients may achieve the ″trifecta″? - Abstract
August 1, 2011
Biochemical recurrence after radical prostatectomy: Is the disease or the surgeon to blame? - Abstract
August 1, 2011
Prostate cancer diagnostics: Innovative imaging in case of multiple negative biopsies - Abstract
July 29, 2011
No association of type-2 diabetes risk variants and prostate cancer risk: The Multiethnic Cohort and PAGE - Abstract
July 29, 2011
Prostatic disease and sexual dysfunction - Abstract
July 29, 2011